Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pathophysiological approach to stroke therapy

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Lassen NA, Fieschi C, Lenzi GL (1991) Ischemic penumbra and neuronal death: Comments on the therapeutic window in acute stroke with particular reference to thrombolytic therapy. Cerebrovasc Dis 1 [Suppl 1]:32–35

  2. 2.

    Baron JC, von Kummer R, del Zoppo GJ (1995) Treatment of acute ischemic stroke. Stroke 26:2219–2221

  3. 3.

    Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of cerebral infarction. Lancet 337:1521–1526

  4. 4.

    Pinto AN, Melo TP, Lourenco ME, Leandro MJ, Brazio A, Carvalho L, Franco AS, Ferro JM (1998) Can a clinical classification of stroke predict complications and treatments during hospitalization? Cerebrovasc Dis 8(4):204–209

  5. 5.

    Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L (1989) Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91(3):311–321

  6. 6.

    Dyker AG, Less KR (1998) Duration of neuroprotective treatment for ischemic stroke. Stroke 29:535–542.

  7. 7.

    Rothrock JF, Clark WM, Lyden PD (1995) Spontaneous rearly improvement following ischemic stroke. Stroke 26:1358–1360

  8. 8.

    Chiu D, Kriger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC (1998) Intravenous tissue piasminogen activator for acute ischemic stroke. Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29:18–22

  9. 9.

    Toni D, Fiorelli M, Zanette EM, Sacchetti ML, Salerno A, Argentino C, Solaro M, Fieschi C (1998) Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography. Stroke 29:1144–1148

  10. 10.

    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahange M, Hennerici M (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025.

  11. 11.

    Multicenter Acute Stroke Trial-Italy (MAST-I) Group (1995) Randomised controlled trial of stroptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 346:1509–1514

  12. 12.

    The Multicenter Acute Stroke Trial-Europe Study Group (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 18;335(3):145–150

  13. 13.

    Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR (1996) Streptokinase for acute ischemic stroke with relationship to time of administration: australian Streptokinase (ASK) Trial Study Group. JAMA 25;276(12):961–966

  14. 14.

    von Kummer R, Holle R, Rosin L, Forsting M, Hacke W (1995) Does arterial recanalization improve outcome in carotid territory stroke? Stroke 26:581–587.

  15. 15.

    del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowely HA, Gent M, and the PROACT investigators (1998) PROACT: A phase II randomized trial of recombinat prourokinase by direct arterial delivery in acute middile cerebral artery stroke. Stroke 29:4–11

  16. 16.

    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

  17. 17.

    Sandercock P (1998) What questions can large, simple trials answer? Cerebrovasc Dis 8 (S2):30–36

  18. 18.

    Sacchetti ML, Toni D, Fiorelli M, Argentino C, Fieschi C (1997) The concept of combination therapy in acute ischemic stroke. Neurology 49[Suppl 4]:S1-S5

  19. 19.

    Grotta J (1997) Lubeluzole treatment of acute ischemic stroke. Stroke 28:2338–2346

  20. 20.

    Hacke W (1998) The results of the European Cooperative Stroke Sudy II (ECASS II), a placebo-controlled, randomized study of trombolytic therapy. Eur Neurol 5[Suppl 3]:59

  21. 21.

    Lenzi GL, Grigoletto F, Gent M, Roberts RS, Walker MD, Easton DJ, Carolei A, Dorsey FC, Rocca WA, Bruno R, Patarnello F, Fieschi C (1994) Early treatment of stroke with Monosialogangloside GM-1. Efficay and safety results of the early stroke trial. Stroke 25:1552–1558

  22. 22.

    Baron JC, Marchal G (1996) SPECT using 99mTc-HMPAO versus neurological scales to predict outcome of acute cerebral infarction. Stroke 27:1253–1254

  23. 23.

    CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischemic stroke. Lancet 349:1641–1649

  24. 24.

    Marchal G, Furlan M, Beadouin V, Rioux P, Hauttement JL, Serrati C, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC (1996) Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome? Brain 119[Pt2]:409–419

  25. 25.

    Feeney DM, Baron JC (1986) Diaschisis. Stroke 17:817–830

Download references

Author information

Correspondence to G. L. Lenzi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lenzi, G.L., Altieri, M., Bruti, G. et al. Pathophysiological approach to stroke therapy. Ital J Neuro Sci 19, S4–S7 (1998). https://doi.org/10.1007/BF00713866

Download citation

Keywords

  • Ischemic Stroke
  • Streptokinase
  • Acute Ischemic Stroke
  • Ischemic Penumbra
  • Middle Cerebral Artery Territory